J&J liable for $572 million in Oklahoma opioid epidemic trial; shares rise

By Heide Brandes and Nate Raymond NORMAN, Okla./BOSTON (Reuters) - An Oklahoma judge on Monday ordered Johnson & Johnson to pay $572.1 million to the state for its part in fuelling an opioid epidemic by deceptively marketing addictive painkillers, a sum that was substantially less than investors had expected, driving up J&J's shares. The state's attorney general had filed the lawsuit, seeking $17 billion to address the impact of the drug crisis on Oklahoma.

The post J&J liable for $572 million in Oklahoma opioid epidemic trial; shares rise appeared first on Firstpost.

from Firstpost